Literature DB >> 17362800

A critical overview of the pharmacologic management of treatment-resistant depression.

Andrew A Nierenberg1, Judith Katz, Maurizio Fava.   

Abstract

Major depressive disorder is a frequent, serious disorder that usually responds partially to treatment and leaves many patients with treatment resistance. This article reviews and critically evaluates the evidence for the management of treatment-resistant depression and examines pharmacologic approaches to alleviate the suffering of patients who benefit insufficiently from initial treatment.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17362800     DOI： 10.1016/j.psc.2007.01.001

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN： 0193-953X


  9 in total

Review 1.  Elderly patients with schizophrenia and depression: diagnosis and treatment.

Authors:  Kandi Felmet; Sidney Zisook; John W Kasckow
Journal:  Clin Schizophr Relat Psychoses       Date:  2011-01

Review 2.  Repetitive Transcranial Magnetic Stimulation for the Treatment of Resistant Depression: A Scoping Review.

Authors:  Medard Kofi Adu; Reham Shalaby; Pierre Chue; Vincent I O Agyapong
Journal:  Behav Sci (Basel)       Date:  2022-06-17

Review 3.  Co-occurring depressive symptoms in the older patient with schizophrenia.

Authors:  John W Kasckow; Sidney Zisook
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 4.  Aripiprazole: in major depressive disorder.

Authors:  Juliane Weber; Katherine A Lyseng-Williamson; Lesley J Scott
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

5.  Sequential multiple-assignment randomized trial design of neurobehavioral treatment for patients with metastatic malignant melanoma undergoing high-dose interferon-alpha therapy.

Authors:  S Freda Auyeung; Qi Long; Erica Bruce Royster; Smitha Murthy; Marcia D McNutt; David Lawson; Andrew Miller; Amita Manatunga; Dominique L Musselman
Journal:  Clin Trials       Date:  2009-09-28       Impact factor: 2.486

6.  Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depression.

Authors:  Naji C Salloum; Maurizio Fava; Rebecca S Hock; Marlene P Freeman; Martina Flynn; Bettina Hoeppner; Cristina Cusin; Dan V Iosifescu; Madhukar H Trivedi; Gerard Sanacora; Sanjay J Mathew; Charles Debattista; Dawn F Ionescu; George I Papakostas
Journal:  J Affect Disord       Date:  2019-09-03       Impact factor: 4.839

7.  Pharmacological interventions for treatment-resistant depression in adults.

Authors:  Philippa Davies; Sharea Ijaz; Catherine J Williams; David Kessler; Glyn Lewis; Nicola Wiles
Journal:  Cochrane Database Syst Rev       Date:  2019-12-17

Review 8.  Psychological therapies for treatment-resistant depression in adults.

Authors:  Sharea Ijaz; Philippa Davies; Catherine J Williams; David Kessler; Glyn Lewis; Nicola Wiles
Journal:  Cochrane Database Syst Rev       Date:  2018-05-14

Review 9.  The Anti-Inflammatory Role of Omega-3 Polyunsaturated Fatty Acids Metabolites in Pre-Clinical Models of Psychiatric, Neurodegenerative, and Neurological Disorders.

Authors:  Juliette Giacobbe; Bonnie Benoiton; Patricia Zunszain; Carmine M Pariante; Alessandra Borsini
Journal:  Front Psychiatry       Date:  2020-02-28       Impact factor: 4.157
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.